Osiris Therapeutics Revenue and Competitors

Columbia, MD USA

Location

$95M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Osiris Therapeutics's estimated annual revenue is currently $300M per year.(i)
  • Osiris Therapeutics's estimated revenue per employee is $1,685,393
  • Osiris Therapeutics's total funding is $95M.

Employee Data

  • Osiris Therapeutics has 178 Employees.(i)
  • Osiris Therapeutics grew their employee count by -1% last year.

Osiris Therapeutics's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
Regional Sales SpecialistReveal Email/Phone
3
National Accounts ManagerReveal Email/Phone
4
Sr. Quality AssociateReveal Email/Phone
5
Receiving AssociateReveal Email/Phone
6
manufacturing associateReveal Email/Phone
7
NY Senior Sales ManagerReveal Email/Phone
8
Quality Assurance AssociateReveal Email/Phone
9
Sr. Quality Control AssociateReveal Email/Phone
10
Regional Account ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Osiris Therapeutics?

Osiris Therapeutics, Inc., is a private development stage biotechnology company that develops adult mesenchymal stem cells (`MSCs") for the regeneration of bone marrow stroma, bone, cartilage and heart muscle tissues that have been damaged by injury, aging or degenerative disease. Osiris is also developing adult MSCs as a delivery platform for gene therapy.

keywords:N/A

$95M

Total Funding

178

Number of Employees

$300M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Osiris Therapeutics News

2022-04-17 - Global Stem Cells Market 2022 Growth Opportunities and ...

Osiris Therapeutics; NuVasive; Chiesi Pharmaceuticals; Medi-post; JCR Pharmaceutical; MolMed; Pharmicell; Anterogen; Takeda (TiGenix); CBR...

2022-04-17 - Stem Cell Therapy Market Size And Forecast | Osiris Therapeutics ...

Osiris Therapeutics Medipost Co. Ltd., Anterogen Co. Ltd., Pharmicell Co. Ltd., HolostemTerapieAvanzateSrl, JCR Pharmaceuticals Co.

2022-03-30 - Umbilical Cord Blood (UCB) Stem Cell Market size worth $ 12.06 ...

In April 2019, Osiris Therapeutics, Inc. Announces the Closing of Acquisition by Smith & Nephew plc through the consummation of a merger of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.3M179-14%N/A
#2
$66M1833%N/A
#3
$29.7M1868%N/A
#4
$7.5M18633%N/A
#5
$36M18714%N/A